Methylphenidate Combined with Aripiprazole in Children and Adolescents with Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder: A Randomized Crossover Trial-Reference-Cited by-同舟云学术

Methylphenidate Combined with Aripiprazole in Children and Adolescents with Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder: A Randomized Crossover Trial

Published:2009-10 Issue:5 Volume:19 Page:553-561
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Zeni Cristian Patrick¹,Tramontina Silzá¹,Ketzer Carla Ruffoni¹,Pheula Gabriel Ferreira¹,Rohde Luis Augusto¹

Affiliation:

1. Juvenile Bipolar Disorder Outpatient Program (ProCAB), Division of Child and Adolescent Psychiatry, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Brasil.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2009.0037

Reference38 articles.

1. Phenomenology of Children and Adolescents With Bipolar Spectrum Disorders

2. Systematic Chart Review of the Pharmacologic Treatment of Comorbid Attention Deficit Hyperactivity Disorder in Youth with Bipolar Disorder

3. An Open-Label Trial of Aripiprazole Monotherapy in Children and Adolescents with Bipolar Disorder

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the management of bipolar disorder in children and adolescents: an update on the literature;Expert Review of Neurotherapeutics;2024-08-05

2. Is Stimulant Treatment in Children and Adolescents with Mood Dysregulation Associated with Adverse Outcomes?;OBM Integrative and Complementary Medicine;2024-06-04

3. Mood Disorders with Attention-Deficit/Hyperactivity Disorder, Impulse Control Disorders, or Borderline Personality Disorder;Clinical Textbook of Mood Disorders;2024-05-30

4. Prescribed psychostimulants and other pro‐cognitive medications in bipolar disorder: A systematic review and meta‐analysis of recurrence of manic symptoms;Bipolar Disorders;2024-04-26

5. Efficacy and safety of established and off‐label ADHD drug therapies for cognitive impairment or attention‐deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force;Bipolar Disorders;2024-03-03